1. Home
  2. IMRN vs TLIH Comparison

IMRN vs TLIH Comparison

Compare IMRN & TLIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$1.12

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

TLIH

Ten-League International Holdings Limited Ordinary Shares

N/A

Current Price

$0.43

Market Cap

12.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IMRN
TLIH
Founded
1994
1998
Country
Australia
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
12.7M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
IMRN
TLIH
Price
$1.12
$0.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2M
433.7K
Earning Date
08-29-2025
09-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.10
Revenue
$4,777,422.00
$51,204,304.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.25
Revenue Growth
48.63
N/A
52 Week Low
$1.05
$0.31
52 Week High
$2.48
$7.00

Technical Indicators

Market Signals
Indicator
IMRN
TLIH
Relative Strength Index (RSI) 28.95 N/A
Support Level $1.42 N/A
Resistance Level $1.78 N/A
Average True Range (ATR) 0.14 0.00
MACD -0.03 0.00
Stochastic Oscillator 9.59 0.00

Price Performance

Historical Comparison
IMRN
TLIH

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

Share on Social Networks: